| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/07/2002 | WO2002018418A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | WO2001079269A3 Lipid binding protein 4 |
| 03/07/2002 | WO2001077181A3 Anti-rhesus d monoclonal antibodies |
| 03/07/2002 | WO2001059075A8 Improved sialylation of glycoproteins |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001051636A3 Secreted proteins |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001044808A3 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/07/2002 | WO2001042285A3 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | WO2001038360A3 Novel hcv non-structural polypeptide |
| 03/07/2002 | WO2001031008A3 Human and rat fgf-20 genes and gene expression products |
| 03/07/2002 | WO2001031006A3 Serum amyloid a isoform from colostrum |
| 03/07/2002 | WO2001029220A3 Mage-a12 antigenic peptides and uses thereof |
| 03/07/2002 | WO2001029218A3 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 03/07/2002 | WO2001021654A3 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/07/2002 | WO2001011086A3 Methods of screening for angiogenesis modulators |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | WO2000056352A3 Reagents and methods useful for detecting diseases of the prostate |
| 03/07/2002 | US20020028915 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028771 Sulfonylation core antibiotic |
| 03/07/2002 | US20020028769 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 03/07/2002 | US20020028495 Deoxyribonuclease II beta proteins and cDNAs |
| 03/07/2002 | US20020028487 Polypeptide; for use in detection of cell cycle modulators |
| 03/07/2002 | US20020028486 Adjusting affinity of immunoglobulins; generate expression vector, insert preferential sequences, express vector in cells, recover preferential immunoglobulin |
| 03/07/2002 | US20020028485 Polypeptide; for use in diagnosis and treatment of cancer, lung, cardiovascular, inflammation, kidney, pain, psychological and nervous system disorders |
| 03/07/2002 | US20020028484 Expression vector for use in the treatment and prevention of viral diseases |
| 03/07/2002 | US20020028473 Components of dense microspheres derived from mammalian brain tissue detectable in cerebrospinal fluid |
| 03/07/2002 | US20020028449 26 Human secreted proteins |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028433 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 03/07/2002 | US20020028207 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/07/2002 | US20020028205 May be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1; absorber to prevent a hyperacute rejection of a xenotransplant |
| 03/07/2002 | US20020028204 Inhibits ristocetin-induced platelet aggregation), botrocetin-induced platelet aggregation, and shear stress-induced platelet aggregation of human platelet, and which does not express bleeding action |
| 03/07/2002 | US20020028203 T cell inhibitory receptor compositions and uses thereof |
| 03/07/2002 | CA2420876A1 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | CA2420765A1 Anti-angiogenic peptides |
| 03/07/2002 | CA2420659A1 Genes expressed in the cell cycle |
| 03/07/2002 | CA2420591A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | CA2420567A1 Mass spectrometric analysis of biopolymers |
| 03/07/2002 | CA2420277A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | CA2420105A1 Human kinases |
| 03/07/2002 | CA2420062A1 Erbb4 antagonists |
| 03/07/2002 | CA2419342A1 G-protein coupled receptors |
| 03/06/2002 | EP1184459A2 Manipulation of gene copy number in Bordetella |
| 03/06/2002 | EP1184454A2 Nav2 channel gene-deficient non-human animals |
| 03/06/2002 | EP1184391A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1184390A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1183386A1 Tm4sf receptors |
| 03/06/2002 | EP1183364A1 Groel muteins with improved stability |
| 03/06/2002 | EP1183362A1 Il-1 eta dna and polypeptides |
| 03/06/2002 | EP1183360A2 Modified cytokine for its stabilisation |
| 03/06/2002 | EP1183359A2 Nucleic acids and proteins with interferon-beta activity |
| 03/06/2002 | EP1183357A2 Vascular endothelial growth factor dimers |
| 03/06/2002 | EP1183356A2 Gustatory receptors in drosophila |
| 03/06/2002 | EP1183355A1 T-bet compositions and methods of use thereof |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 03/06/2002 | EP1183351A1 Phospholipid transfer protein |
| 03/06/2002 | EP1183349A1 Tumor-associated antigen (c42) |
| 03/06/2002 | EP1183346A1 Method for generating split, non-transferable genes that are able to express an active protein product |
| 03/06/2002 | EP1183275A2 Combined approach to treatment of cancer with hcg vaccines |
| 03/06/2002 | EP1183272A2 49 human secreted proteins |
| 03/06/2002 | EP1183270A2 Novel organic anion transport proteins |
| 03/06/2002 | EP1183268A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 03/06/2002 | EP0938505B1 Anti-endoglin monoclonal antibodies and their use in anti-angiogenesis therapy |
| 03/06/2002 | EP0820516B1 Exopolysaccharide degrading enzyme and use of the same |
| 03/06/2002 | EP0710110B1 Antibodies of ring opened rapamycins |
| 03/06/2002 | CN1339107A Method of identifying N-terminal proBNP |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1339065A Method for preparing highly pure albumin solution |
| 03/06/2002 | CN1338473A Fusion protein with angiogenesis suppression action |
| 03/06/2002 | CN1080312C Rapamycin assay |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080308C Antikanamycin gene originated from microbe |
| 03/06/2002 | CN1080307C Method and system for enhanced production of commercially important exoproteins in grampositive bacteria |
| 03/06/2002 | CN1080305C Preparation of hepatocellular cearcinoma oncogene |
| 03/06/2002 | CN1080304C Method for preparing modified L-protein for hepatitis B virus |
| 03/06/2002 | CN1080303C Antimicrobial proteins |
| 03/06/2002 | CN1080124C Pneumococcal polysaccharide conjugate vaccine |
| 03/05/2002 | US6353154 Nucleic acid molecules encoding starch phosphorylase from maize |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6352971 Polypeptides with amino acid sequences |
| 03/05/2002 | US6352846 A polypeptide; for transgenic plants with increased crop yields |
| 03/05/2002 | US6352843 YsxC from Staphylococcus aureus |
| 03/05/2002 | US6352842 Exonucease-mediated gene assembly in directed evolution |
| 03/05/2002 | US6352841 Host cells and methods of producing proteins |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | US6352832 Anti-CCR2 antibodies and methods of use therefor |
| 03/05/2002 | CA2356553A1 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 02/28/2002 | WO2002016952A2 Detecting polymers and polymer fragments |
| 02/28/2002 | WO2002016945A1 Chemical sensor and method of detecting chemical |
| 02/28/2002 | WO2002016937A1 Method of screening remedy for heart failure |
| 02/28/2002 | WO2002016658A1 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 02/28/2002 | WO2002016657A1 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 02/28/2002 | WO2002016626A1 Expression vector containing urea cycle enzyme gene, transformant thereof, and use of transformant for protein over-expression |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016597A2 Lipid metabolism enzymes |